Search for Clinical Trial Results
Anemia, Hypoplastic, Congenital - 14 Studies Found
Status | Study |
Completed |
Study Name: Pilot Study of Etanercept (Enbrel) in Children With Fanconi Anemia Condition: Fanconi Anemia Date: 2009-08-24 Interventions: Drug: Etanercept All qualified subjects receive 24 weekly subcutaneous injections of Etanercept. |
Recruiting |
Study Name: Microcephaly Genetic Deficiency in Neural Progenitors Condition: Microcephaly Date: 2012-02-29 |
Recruiting |
Study Name: Lentiviral-mediated Gene Therapy of Fanconi Anemia Patients Subtype A Condition: Fanconi Anemia Date: 2017-04-26 Interventions:
|
Recruiting |
Study Name: Clinical Phase II Trial to Evaluate CD34+ Cells Mobilization and Collection in Patients With Fanconi Anemia for Subsequent Transduction With a Lentiviral Vector Carring FANCA Gene. FANCOSTEM-1 Condition: Fanconi Anemia Date: 2016-09-06 Interventions:
|
Recruiting |
Study Name: Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and Plerixafor Condition: Fanconi Anemia Date: 2016-02-05 Interventions:
|
Enrolling by invitation |
Study Name: Unrelated HSCT in Patients With Fanconi Anemia Condition: Fanconi Anemia Date: 2012-10-19 Interventions: Biological: CD34+ selected cells Compassionate treatment of Fanconi Anemia patients with unrelated bone |
Recruiting |
Study Name: Quercetin in Children With Fanconi Anemia; a Pilot Study Condition: Fanconi Anemia Date: 2012-07-25 Interventions: Drug: Quercetin (dietary supplement) Quercetin will be given orally on a twice a day schedule starting w |
Recruiting |
Study Name: Gene Therapy for Fanconi Anemia Condition: Fanconi Anemia Date: 2011-03-16 Interventions:
|
Completed |
Study Name: Multicenter Transplant Study for Fanconi Anemia Condition: Fanconi Anemia Date: 2010-03-05 Interventions:
|
Active, not recruiting |
Study Name: Hematopoietic Stem Cell Transplant for Fanconi Anemia Condition: Fanconi Anemia Date: 2009-05-20 Interventions: Device: CliniMACs device Donor Peripheral blood progenitor cells will use CD34+ selection with the use o |